tiprankstipranks
Advertisement
Advertisement

DE:TD5A Stock Latest News

Tandem Diabetes price target lowered to $20 from $24 at Mizuho
The FlyTandem Diabetes price target lowered to $20 from $24 at Mizuho
9d ago
TNDM
Insulet price target lowered to $245 from $280 at RBC Capital
PremiumThe Fly
Insulet price target lowered to $245 from $280 at RBC Capital
10d ago
PODD
TNDM
Tandem Diabetes launches t:slim X2 compatibility with Abbott’s FreeStyle
PremiumThe Fly
Tandem Diabetes launches t:slim X2 compatibility with Abbott’s FreeStyle
22d ago
ABT
TNDM
Tandem Diabetes initiated with a Hold at Deutsche Bank
PremiumThe Fly
Tandem Diabetes initiated with a Hold at Deutsche Bank
1M ago
TNDM
Tandem Diabetes: Neutral Stance Maintained as Mobi Tubeless Opportunity Balances Execution Risks; $25 Price Target Unchanged
PremiumRatings
Tandem Diabetes: Neutral Stance Maintained as Mobi Tubeless Opportunity Balances Execution Risks; $25 Price Target Unchanged
1M ago
TNDM
Tandem Diabetes receives CE Mark for expanded indications of AID systems
PremiumThe FlyTandem Diabetes receives CE Mark for expanded indications of AID systems
2M ago
TNDM
Microsoft initiated, Dell upgraded: Wall Street’s top analyst calls
Premium
The Fly
Microsoft initiated, Dell upgraded: Wall Street’s top analyst calls
2M ago
KR
ZS
Wells upgrades Tandem Diabetes on ‘transformational’ pharmacy model
Premium
The Fly
Wells upgrades Tandem Diabetes on ‘transformational’ pharmacy model
2M ago
TNDM
Tandem Diabetes upgraded to Overweight from Equal Weight at Wells Fargo
PremiumThe Fly
Tandem Diabetes upgraded to Overweight from Equal Weight at Wells Fargo
2M ago
TNDM
Tandem Diabetes price target lowered to $17 from $22 at Citi
PremiumThe Fly
Tandem Diabetes price target lowered to $17 from $22 at Citi
2M ago
TNDM
Tandem Diabetes price target lowered to $21 from $24 at Goldman Sachs
PremiumThe Fly
Tandem Diabetes price target lowered to $21 from $24 at Goldman Sachs
2M ago
TNDM
Tandem Diabetes Shareholders Approve Governance and Incentive Changes
PremiumCompany Announcements
Tandem Diabetes Shareholders Approve Governance and Incentive Changes
2M ago
8K
TNDM
Tandem Diabetes Care Rides Record Quarter, Reaffirms Outlook
PremiumCompany AnnouncementsTandem Diabetes Care Rides Record Quarter, Reaffirms Outlook
2M ago
TNDM
Tandem Diabetes price target lowered to $25 from $35 at BofA
Premium
The Fly
Tandem Diabetes price target lowered to $25 from $35 at BofA
2M ago
TNDM
Tandem Diabetes Care Announces Leadership Change, Strategy Unchanged
Premium
Company Announcements
Tandem Diabetes Care Announces Leadership Change, Strategy Unchanged
2M ago
8K
TNDM
Toast downgraded, Lowe’s upgraded: Wall Street’s top analyst calls
PremiumThe Fly
Toast downgraded, Lowe’s upgraded: Wall Street’s top analyst calls
2M ago
GE
GTM
Tandem Diabetes initiated with a Hold at Benchmark
PremiumThe Fly
Tandem Diabetes initiated with a Hold at Benchmark
2M ago
TNDM
Tandem Diabetes initiated with a Hold at Benchmark
PremiumThe Fly
Tandem Diabetes initiated with a Hold at Benchmark
2M ago
TNDM
Tandem Diabetes price target lowered to $55 from $56 at Barclays
PremiumThe Fly
Tandem Diabetes price target lowered to $55 from $56 at Barclays
2M ago
TNDM
Tandem Diabetes Care Charts Growth Amid Transition
PremiumCompany AnnouncementsTandem Diabetes Care Charts Growth Amid Transition
3M ago
TNDM
Analyst Reiterates Buy on Tandem, Maintains $35 Price Target Amid Transformation and Margin Expansion Prospects
Premium
Ratings
Analyst Reiterates Buy on Tandem, Maintains $35 Price Target Amid Transformation and Margin Expansion Prospects
3M ago
TNDM
Tandem Diabetes price target raised to $24 from $22 at Mizuho
Premium
The Fly
Tandem Diabetes price target raised to $24 from $22 at Mizuho
3M ago
TNDM

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >